The soluble epoxide hydrolase inhibitor tppu improves comorbidity of chronic pain and depression via the ahr and tspo signaling

HIGHLIGHTS

  • who: Ailin Luo from the Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China have published the paper: The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling, in the Journal: (JOURNAL)
  • what: The aim of this study was to elucidate the role of sEH in the chronicpain-depression comorbidity induced by SNI surgery.
  • how: The study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?